Ask AI
ProCE Banner Events

Share

Individualized Management of AML: Guidance for the Community Multidisciplinary Team [Open Registration]

Register now for this case-based workshop series on managing AML in older patients with AML and those with FLT3- or IDH1/2-mutated AML, including a discussion on managing key adverse events associated with targeted therapy.

To Register: Please click the green “Learn More” button below. On the next page, select Register for Virtual Event. Once registered, you will receive a confirmation email. Follow-up emails with event details will be sent as the event nears.

Nurse Practitioners/Nurses: 1.00 Nursing contact hour

Pharmacists: 1.00 contact hour (0.1 CEUs)

Physicians: maximum of 1.00 AMA PRA Category 1 Credit

This event has expired. No longer available for credits.

Credits Available

1.0

Who Should Attend

This program is intended for hematologists, oncologists, nurses, pharmacists, and other healthcare professionals involved in the treatment of patients with AML.

Time and location

Monday, November 06, 2023

11:30 AM - 12:30 PM Central Time (CT)

Virtual

CCO Simulcast | Host Group TX
Dallas, Texas

Agenda

Welcome & Demographic Polling

Discussion 1:  Older Patient with Newly Diagnosed AML Who is Ineligible for Intensive Induction Chemotherapy

  • Therapeutic options based on patient fitness and cytogenetic factors 

Discussion 2: Exploring AML Cases With Mutant IDH1/IDH2

  • Selective inhibitors of mutant IDH1/2
  • Managing treatment-related AEs associated with IDH inhibitors

Discussion 3: Newly Diagnosed FLT3-ITD Mutated AML

  • Clinical trial data on approved and investigational FLT3 inhibitors 
  • Managing treatment-related AEs associated with FLT3 inhibitors

Audience Question & Answer

Location

Venue Name

CCO Simulcast | Host Group TX

Address

CCO Simulcast | Host Group TX
Dallas, Texas

CME/CE Info

Goal Statement
The goal of this activity is to improve the knowledge, confidence, competence, and performance of community multidisciplinary teams in integrating the available clinical data, guidelines, and expert recommendations into the care of their patients with AML.

Target Audience
This program is intended for hematologists, oncologists, nurses, pharmacists, and other healthcare professionals involved in the treatment of patients with AML. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Develop genetic testing strategies that incorporate best communication techniques and expert guidance for all patient subgroups with AML that may benefit from targeted therapy
  • Evaluate the clinical data on prognostic or predictive molecular features or aberrations in AML and describe their clinical importance in terms of diagnosis, risk prediction, assessment of measurable residual disease, and therapeutic decisions
  • Plan individualized AML therapeutic strategies considering the molecular profile along with available clinical evidence on efficacy and potential toxicities
  • Implement plans to educate patients

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-0000-23-127-L01-P 

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC.

Supported by educational grants from AbbVie Inc. and Daiichi Sankyo, Inc.

Contact Information

Contact Clinical Care Options

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.